FTC Taps Cephalon Again Over Provigil Deal
Amid growing concerns over the anti-competitive effects of deals that keep generics off the market, the U.S. Federal Trade Commission subpoenaed Cephalon Inc. for information regarding its patent infringement settlements for...To view the full article, register now.
Already a subscriber? Click here to view full article